Latest News

SGLT2 inhibitors tied to lower risk of incident gout vis a vis sulfonylureas in diabetes patients: JAMA

USA: The use of SGLT2 inhibitors versus sulfonylureas was associated…

Does yoghurt help in prevention of diabetes and obesity?

A recent study published in Frontiers in Nutrition discussed…

Rivaroxaban Plus Aspirin Shows Favorable Benefit-Risk Profile in PAD Patients after revascularization, suggests study

The VOYAGER PAD trial evaluated the efficacy and safety of rivaroxaban…
Facebook Comments